Towards a TB-Free India

1. At a Glance

• TB Mukt Bharat is India's push to eliminate tuberculosis. It runs under the National TB Elimination Programme (NTEP), which follows the National Strategic Plan (NSP) 2017–2025 and its Detect–Treat–Prevent–Build (DTPB) framework [2].
• India set out to eliminate TB by 2025, five years ahead of the global 2030 target [2]. The 2025 deadline has now passed without elimination, so expect questions that ask you to evaluate the programme.
• India has the largest share of the world's TB cases (25% in 2024) and 32% of the world's MDR/RR-TB [10]. Its outcomes therefore shape global End TB progress.
• The topic covers GS-II (health and welfare schemes), GS-III (science and technology, including AI diagnostics and new drug regimens) and GS-IV (stigma and community responsibility).

2. Why in the News

• 13 Oct 2026: PIB reported a 21% decline in TB incidence in India over 2015–2024, against a 12% decline globally. It also reported 92% treatment coverage against 78% globally and a 28% fall in TB deaths, all based on the WHO Global TB Report 2025 [1].
• 13 Oct 2026: The JOSH (Joint Squad for Health) campaign began as a pilot in 11 states and 55 districts [1].
• 12 Nov 2025: WHO released the Global TB Report 2025. It found that the world is far off the End TB milestone of a 50% incidence cut by 2025 [9].
• 7 Dec 2024 onwards: A 100-Day intensified TB Mukt Bharat Abhiyaan ran in 347 high-priority districts [5]. It was later scaled up to all districts [7].

3. Background & Evolution

• 1882: Robert Koch discovered the TB bacterium. World TB Day (24 March) marks this discovery, and India has observed the day since 1982 [2].
• 2017: The National Strategic Plan 2017–2025 was adopted, built on the DTPB pillars [2].
• 2018: The Ni-kshay Poshan Yojana (NPY) began paying TB patients through Direct Benefit Transfer (DBT). The press releases also link 2018 to the NIKSHAY notification incentive for private-sector providers [2][6].
• 2020: The Revised National TB Control Programme (RNTCP) was renamed the National TB Elimination Programme (NTEP) [2].
• 9 Sep 2022: President Droupadi Murmu launched the Pradhan Mantri TB Mukt Bharat Abhiyaan (PMTBMBA), which includes the Ni-kshay Mitra initiative [3].
• Sep 2024: The Health Ministry approved the BPaLM regimen for drug-resistant TB [4].
• Dec 2024 – Mar 2025: The 100-Day campaign ran. At the World TB Day 2025 Summit, the Health Minister announced it would be extended to all districts [5][7].
• Oct 2026: The JOSH campaign launched as the next step in the Jan Andolan (people's movement) approach [1].

4. Core Static Facts

5. Multi-Dimensional Analysis

Social

• Undernutrition drives TB. That is why NPY, EDNS and Ni-kshay Mitra food baskets focus on nutrition [2].
• Stigma discourages people from seeking care. JOSH aims to build stigma-free communities, especially among vulnerable and marginalised groups [1].
• The 100-Day campaign screened 12.97 crore vulnerable people. It found 7.19 lakh cases, including 2.85 lakh asymptomatic ones [6]. This shows how much TB goes undetected without active screening.

Economic / Fiscal

• About ₹3,202 crore has been paid out under NPY, with ₹1,040 crore more committed and shared between Centre and States [2].
• PMTBMBA brings in CSR (corporate social responsibility) funding and private donors, which adds to public money [2].
• An ICMR study found BPaLM highly cost-effective: about ₹37 extra per patient for each additional quality-adjusted life year (QALY) compared with the standard regimen [8].
• Global TB funding is falling, which threatens programme continuity [2].

Scientific / Technological

• Handheld X-ray screening has increased 34-fold. Other tools include AI-driven triage and the TB Mukt Bharat App with its AI chatbot 'Khushi' [1].
• India built its first indigenous TB burden model, a mathematical model that gives state-wise estimates [2].
• On drug-resistant TB, treatment success rose from 68% (2020) to 75% (2022) with the all-oral bedaquiline regimen. The 6-month regimen succeeds in about 80% of MDR-TB cases [2].

Governance / Administrative

• Gram Panchayats have been certified TB-free (46,118 so far), and there is a sub-national TB-free certification system that uses surveys and tracking of drug sales [1][2].
• 560 medical colleges support detection and research through a task force [2].
• The number of "missing" (unreported) TB cases fell from 15 lakh (2015) to 2.5 lakh (2023) [2]. Even so, India still accounts for 8.8% of the global gap between estimated and notified cases [10].
• The programme works across ministries: MY Bharat volunteers, NCC cadets and Class-I officers make up the JOSH teams [1].

Ethical

• Community volunteering, through the Jan Andolan approach and Ni-kshay Mitras, puts duty-based citizenship into practice. The risk is that the state relies on charity for a basic entitlement like nutrition [1][2].

Geopolitical / Global

• India carries 25% of global TB cases and 32% of global MDR/RR-TB [10], so global milestones cannot be met without India.
• Globally, incidence fell only 12% between 2015 and 2024, against the 50% End TB milestone for 2025 [9].

6. Recent Developments (last 12–18 months)

• May 2025: The PM reviewed PMTBMBA. The 100-Day campaign had screened 12.97 crore people and found 7.19 lakh cases [6].
• Mar 2025: The World TB Day theme was "Yes! We Can End TB: Commit, Invest, Deliver". The campaign was extended to all districts [2][7].
• 12 Nov 2025: WHO released the Global TB Report 2025 [9].
• 2025–26: An ICMR study published by PIB found shorter all-oral drug-resistant TB regimens cost-effective [8].
• 13 Oct 2026: PIB reported cumulative screenings of 28.1 crore, over 20 lakh people on TB Preventive Treatment (TPT), 5.7 lakh new Ni-kshay Mitras and 46,118 TB-free Gram Panchayats. The JOSH campaign also launched [1].

7. Prelims Hooks

• PMTBMBA was launched on 9 Sep 2022 by President Droupadi Murmu, not the PM [3].
• RNTCP was renamed NTEP in 2020 [2].
• The NTEP follows the NSP 2017–2025 with the Detect–Treat–Prevent–Build pillars [2].
• NPY nutrition support is ₹1,000 per month, up from ₹500 [2].
• EDNS covers TB patients with BMI below 18.5 for the first 2 months of treatment [2].
• A Ni-kshay Mitra adopts a patient for at least 6 months [2].
• BPaLM = Bedaquiline + Pretomanid + Linezolid + Moxifloxacin. It was approved in Sep 2024 [1][4].
• JOSH = Joint Squad for Health. Each team has MY Bharat volunteers, NCC cadets and a Class-I officer. The pilot covers 11 states and 55 districts [1].
• The AI chatbot 'Khushi' is part of the TB Mukt Bharat App [1].
• WHO Global TB Report 2025: India's incidence fell 21% over 2015–2024, against 12% globally. Deaths fell 28% [1].
• India's treatment coverage is 92%, against 78% globally [1].
• The Ni-kshay portal was developed with NIC and WHO India [2].
• World TB Day is 24 March and marks Robert Koch's discovery in 1882 [2].
• India had 25% of global incident TB cases in 2024, the largest share of any country, followed by Indonesia with 10% [10].

8. Why a 21% Fall Still Leaves India Far From Elimination

• India did better than the world, but not well enough for its own goal
• India's TB incidence (new cases per lakh people each year) fell 21% over 2015–2024. The fall worldwide was 12% [1].
• The End TB milestone asked for a 50% cut by 2025, and India's 2025 target was full elimination, which is much stricter [2][9].

• So India beat the world average but reached less than half of the milestone cut.

• Put in numbers, the gap is large

• India's incidence was 237 per lakh in 2015 and 195 per lakh in 2023 [2].

• A 50% cut would have brought it to about 119 per lakh. India was still about 75 points above that.

• More cases being reported is good news here, not bad news

• India reported 26.07 lakh cases in 2024, its highest ever, even while incidence fell [2].
• This happens because the programme is finding people who were already sick but never counted. "Missing" cases fell from 15 lakh to 2.5 lakh [2].

• In an answer, do not read rising notifications as "TB is spreading". They show that detection has improved.

• The data have a limit

• Incidence is an estimate made with a model, not a direct count. The 21% figure comes from WHO's estimate [1], while India has also built its own state-wise model [2].
• Say which source you are quoting, and for which year. The WHO 2024 report gave 17.7%, and the 2025 report gave 21% [1][2].

9. The TB That Waiting for Symptoms Cannot Find

• Almost 4 in 10 cases found by the campaign had no symptoms
• The 100-Day campaign found 7.19 lakh cases, and 2.85 lakh of them had no symptoms [6].
• The routine programme mostly depends on passive case finding (waiting for sick people with a cough to come to a clinic).

• A person with no symptoms never comes to the clinic, but they can still get worse and later spread TB. Without active screening, these cases stay hidden.

• The tool that found them is used in short campaigns, not every day

• Use of handheld X-ray machines rose 34-fold, and AI tools now help decide who needs a test [1].

• But these finds came from a time-bound drive in 347 districts that was later extended [5][7]. When a campaign ends, the screening stops unless it becomes part of routine work.

• India is still the biggest source of the world's missing cases

• India accounts for 8.8% of the global gap between estimated and reported cases [10].

• Every unreported case is a person who is not on treatment, and may still be passing TB to others.

• What should change

• The Central TB Division should make X-ray screening of high-risk groups a fixed yearly task. High-risk groups include undernourished people and household contacts of patients. The screening could run through Ayushman Arogya Mandirs (primary health centres), not only through campaigns.
• The campaign's own result, about 40% of cases without symptoms, is the evidence for this [6].

10. Food Prevents TB, but Charity Cannot Guarantee the Food

• Hunger is one of the biggest single causes of TB
• WHO estimates that about 0.97 million new TB cases worldwide in 2024 were due to undernutrition (not getting enough food). That is more than for diabetes, alcohol, smoking or HIV [12].

• In WHO's South-East Asia Region, undernutrition and diabetes together cause nearly 8.5 lakh new cases each year [13].

• Indian evidence shows that feeding families cuts TB

• The RATIONS trial in Jharkhand covered 10,345 household contacts of TB patients. About one-third of them were undernourished [11].

• Families who got monthly food rations for at least six months had about 40% fewer TB cases over the next two years [11].

• But in India, food for contacts depends on donors

• Ni-kshay Mitra support now reaches household contacts, but it is voluntary. Donors choose to adopt patients for at least 6 months [2].
• Coverage therefore depends on how many donors come forward and where they live. It is not a right the family can claim.

• The note's ethical point, that the state relies on charity for a basic need, is not just a moral worry. The RATIONS result shows it is a gap in disease control [11].

• ₹1,000 a month is small next to what TB really costs a family

• Worldwide, about half of TB patients and their households face catastrophic costs (total costs above 20% of yearly household income) [14].

• NPY pays ₹1,000 a month [2]. It does not cover the wages lost by the patient or by the family member who cares for them.

• What should change

• MoHFW should fund food for household contacts as a budgeted scheme, not leave it to donors. It can point to the RATIONS result, a 40% drop in TB among contacts, as the reason [11].
• Ni-kshay Mitra donations can then add to this base support instead of being the only support.

11. Drug-Resistant TB: One in Four Still Not Cured

• Success rates are better, but still leave many patients behind
• Treatment success for drug-resistant TB rose from 68% to 75% [2]. That still means about 1 in 4 patients is not successfully treated.

• Even the 6-month regimen works in about 80% of MDR-TB cases (TB that the two main drugs can no longer kill) [2].

• Why this matters beyond India

• India has 32% of the world's MDR/RR-TB [10].

• When treatment fails or is left incomplete, the bacteria can become resistant to even more drugs. This makes MDR-TB a part of the wider AMR (antimicrobial resistance) problem.

• Cheap new drugs only help if patients complete the treatment

• ICMR found BPaLM very cost-effective [8]. But cost-effectiveness assumes that patients finish the course.
• Patients who face hunger and lost income are more likely to stop treatment early. This links back to the nutrition gap above [11][14].

12. The Strongest Case That the Programme Is Working

• The argument
• India's incidence fell almost twice as fast as the world's: 21% against 12% [1].
• India's treatment coverage (the share of estimated patients who get treatment) is 92%, against 78% worldwide [1].
• Missing cases fell from 15 lakh to 2.5 lakh [2], and TB deaths fell 28% [1].

• On this view, missing an extremely ambitious 2025 deadline does not mean the programme failed.

• What this argument gets right

• The 2025 target was five years ahead of the global 2030 target [2]. Even the world as a whole reached only 12% against a 50% milestone [9].

• India's detection and coverage figures are better than the global average, and they really did improve.

• Where it falls short

• Beating the average is not the same as being on track. India's 2023 rate of 195 per lakh is far from the halved level [2].
• The gains depend heavily on campaigns and volunteers [1][6]. The causes that drive new cases, hunger and costs for families, are only partly addressed [11][14].

• Global TB funding is falling [2]. This makes it harder to keep up campaign-style efforts.

• How to use this in an answer: Give credit with the data first, then explain why speed of decline, not a deadline, is the honest test.

13. Anchors for Answers

• Data: India's incidence fell 21% (2015–2024), against 12% worldwide. Treatment coverage is 92%, against 78% worldwide [1]
• Data: 2.85 lakh of the 7.19 lakh cases found in the 100-Day campaign had no symptoms [6]
• Data: About 0.97 million new TB cases worldwide in 2024 were due to undernutrition [12]
• Data: About half of TB-affected households worldwide face catastrophic costs (above 20% of household income) [14]
• Report/Committee: WHO Global TB Report 2025 [9]. National Strategic Plan 2017–2025 [2]
• Comparison: RATIONS trial, Jharkhand — monthly food for household contacts gave about 40% fewer TB cases over two years [11]
• Scheme: Ni-kshay Poshan Yojana (₹1,000 a month by DBT) and Ni-kshay Mitra (voluntary donor support) — together they show the choice between a state entitlement and charity [2]

14. Mains Relevance

• GS-II: Issues relating to the development and management of the social sector and services relating to health; government policies and interventions for vulnerable sections.
• GS-III: Science and technology, including AI in health and indigenisation of technology.
• GS-IV: Stigma, compassion and civic duty, as in the Jan Andolan approach.
• Possible question stems: 1. India missed its 2025 TB elimination target yet outpaced the global decline in incidence. Critically examine the drivers and the remaining gaps. (250 words) 2. Nutritional support is as important as drugs in TB control. Evaluate Ni-kshay Poshan Yojana and the Ni-kshay Mitra initiative in this light. 3. Discuss the role of community mobilisation and technology in accelerating TB elimination in India, with reference to recent initiatives.

15. Related Topics to Study Next

• SDG 3 (Health) and the WHO End TB Strategy: These set the global benchmarks India measures itself against.
• Antimicrobial resistance (AMR): MDR-TB is the clearest example of AMR in India.
• Ayushman Bharat and Ayushman Arogya Mandirs: These primary-care centres are where TB screening reaches the last mile.
• POSHAN Abhiyaan and malnutrition: Undernutrition is a major risk factor for TB.
• Digital health (ABDM, AI in healthcare): Ni-kshay, Khushi and AI triage are part of this ecosystem.
• MY Bharat and NCC: Their youth volunteers form the JOSH teams.
• CSR under the Companies Act: It funds Ni-kshay Mitra support.
• Kala-azar and leprosy elimination: These are comparable disease-elimination programmes.

16. NCERT Concepts to Revise

• Direct Benefit Transfer (Polity): Ni-kshay Poshan Yojana pays TB patients ₹1,000 a month straight into bank accounts through DBT.
• Malnutrition (Economy): Undernutrition is a leading cause of TB, which is why the programme stresses nutrition support and food for contacts.
• Body Mass Index (Economy): Patients with BMI below 18.5 qualify for energy-dense nutritional supplements in the first two months of treatment.
• Corporate social responsibility (Economy): CSR funds and private donors support Ni-kshay Mitra, the voluntary nutrition aid under PMTBMBA.
• Screening (Economy): Active screening, such as X-rays and AI triage, finds TB cases that have no symptoms and would stay hidden.
• President of India (Polity): The President launched PMTBMBA in 2022, a likely Prelims trap since many assume the Prime Minister did.

17. Common Errors / Trap Areas

• Mixing up two WHO report years. The WHO 2024 report gave a 17.7% fall in incidence (237 to 195 per lakh, 2015–2023) [2]. The WHO 2025 report gave 21% for 2015–2024 [1]. Check which year the question refers to.
• Wrong person launching PMTBMBA. It was launched by the President, not the Prime Minister [3].
• Mixing up regimen names. BPaLM includes Moxifloxacin [1]. Some releases say mBPaL or BPaL [2], and BPaL has no Moxifloxacin.
• Confusing the target years. India's target was 2025 and the SDG/global target is 2030 [2]. The NSP period is 2017–2025.
• Confusing NPY with Ni-kshay Mitra. NPY is government DBT cash. Ni-kshay Mitra is voluntary community and CSR support under PMTBMBA [2].